Stockreport

Royalty Pharma: Solid Operational Performance [Seeking Alpha]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF The company increased its dividend per share by 5% and reported adjusted cash receipts that exceeded internal expectations. Royalty Pharma provided new full-year 2024 [Read more]